Quarterly Appendix 4C Cash Flow Report

• Net cash used in operating activities of $834k
• Cash and cash equivalents of $1.752m at quarter end
• Company plans capital raise to fund ongoing operations

Intelicare Holdings Ltd has released its quarterly Appendix 4C cash flow report for the period ended 30 September 2025. The company reported net cash used in operating activities of $834k for the quarter, with cash and cash equivalents of $1.752m at the end of the period. The company has also disclosed that it has a funding facility of $901k secured against its FY26 R&D estimated claim. Looking ahead, Intelicare announced on 15 September 2025 that it is undertaking a capital raise through a Placement of up to $2 million, with the first tranche of approximately $1.827 million already completed. The second tranche of around $173,000 will be issued subject to shareholder approval. The company believes it will be able to continue its operations and meet its business objectives through the capital raise and ongoing cost management initiatives.

The company plans to raise additional capital through a $2 million placement to fund its ongoing operations and meet business objectives.